M-PRAVASTATIN

mantra pharma inc🇨🇦 Health Canada

Approval Id: abd0498ac88c27da
Drug Approval Canada Name: M-PRAVASTATIN
Product Name: M-PRAVASTATIN
Status: Marketed
Status Date: 2025-04-28
Original Market Date: 2018-12-11
Din: 02476290
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:06.08
Atc Original: C10AA03 PRAVASTATIN
Atc Name: c 10 aa 03
Aig Number: 0122563003
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

PRAVASTATIN SODIUM

40 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

abd0498ac88c27da

Type

Standard